TVRD
Tvardi Therapeutics
TVRD
TVRD
160 hedge funds and large institutions have $425M invested in Tvardi Therapeutics in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 32 increasing their positions, 48 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
24% less capital invested
Capital invested by funds: $559M → $425M (-$134M)
33% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 48
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
160
Holding in Top 10
1
Calls
$6.17M
Puts
$3.94M
Top Buyers
| 1 | +$4.26M | |
| 2 | +$3.72M | |
| 3 | +$3.35M | |
| 4 |
First Manhattan
New York
|
+$2.72M |
| 5 |
Renaissance Technologies
New York
|
+$2.67M |
Top Sellers
| 1 | -$6.59M | |
| 2 | -$3.24M | |
| 3 | -$2.45M | |
| 4 |
C
Chescapmanager
Baltimore,
Maryland
|
-$2.16M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
-$2.03M |